You are viewing the UK site. Change your country

How it all works.

Step 1


To qualify you must:

  • Be 60-75 years of age
  • Have not been diagnosed
    with any memory impairment

We have study sites across the UK –
Find your nearest one.

For this program, it is required that you have a study partner. This study partner must agree to participate in the study along with you. Your study partner must also be willing to accompany you on the required twice-yearly visits. In addition, they must spend adequate time with you to be familiar with your overall function and behaviour. They should have a good knowledge of your domestic activities, hobbies, routines, social skills, basic daily life, and general health status.

Step 2

Genetic testing

To proceed, we need to know whether your genetics show that you may have an increased risk of Alzheimer’s. This requires a quick cheek swab test at your local study site.

Only people with the genetic results we are looking for can take part in the Generation Program. Your participation is voluntary and you are able to withdraw from the program at any time.

Step 3


If you’re eligible for the Generation Program and choose to take part, you’ll be joining the fight against Alzheimer’s.

The trials will run for between 5 and 8 years. We know this is a long commitment, but it’s only by running such extensive studies that we can determine if our investigational treatments may be able to help fight Alzheimer’s.

Taking part in such a long trial may seem like a daunting prospect, but by committing these years, there is a chance you could help save more for future generations.


What are
clinical trials?

Clinical trials are research programs to find out if investigational treatments are safe and effective. It’s how we discover whether they can make a real, positive difference to people – or not.

They are essential for the advancement of medical knowledge and help us find new ways to fight and prevent diseases. Every treatment you’ve ever encountered will have gone through several phases of clinical trials.

How they work?

The participants – that’s you – are the most important part. They are given the investigational treatment, or a placebo, and monitored closely by a doctor or other research professionals.

At the end, all of the information is analysed and used to determine whether the investigational treatment can be approved for use by the public. If so, your contribution could benefit many people for generations to come.